跳至主要内容
临床试验/NCT01091818
NCT01091818Unknown3 期

A Prospective, Double-blind Study of Dexmedetomidine Versus Midazolam for Intensive Care Sedation of Children

Ullevaal University Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2010年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
40
试验地点
1
主要终点
Time from end of sedation to extubation

研究概览

简要总结

Dexmedetomidine will be tested against midazolam in a prospective, randomized, double-blind study of intensive care children, age 2-17 years.

The investigators' primary hypothesis is that time from end of medication to extubation will be shorter with dexmedetomidine sedation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
2 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • informed consent from parents
  • age between 2 and 18 years
  • anticipated need of respirator treatment for more than 24 hrs
  • included in study within 48 hrs of admission to intensive care unit (ICU)

排除标准

  • severe, unstable circulatory failure
  • severe intracranial or spinal trauma with circulatory instability
  • sever bradycardia or atrioventricular (A-V) block
  • liver failure
  • less than 50% chance of anticipated survival
  • known allergy to study drugs

研究组 & 干预措施

midazolam

Active Comparator

干预措施: Midazolam (Drug)

dexmedetomidin

Experimental

干预措施: dexmedetomidine (Drug)

结局指标

主要结局

Time from end of sedation to extubation

时间窗: 1-24 hrs

次要结局

未报告次要终点

研究者

发起方
Ullevaal University Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验